CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Activity

52 hedge funds and large institutions have $360M invested in Corvus Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 4 closing their positions.

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
16
Reduced
17
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$8.48M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$16.5M
3
BlackRock
3
BlackRock
New York
$3.71M
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$1.4M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.2M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$44.1M
2
CAM
2
Cormorant Asset Management
Massachusetts
$1.68M
3
ACA
3
Avoro Capital Advisors
New York
$2.53M
4
SFM
4
Sphera Funds Management
Israel
$5.8M
5
Millennium Management
5
Millennium Management
New York
$475K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$2K 117 -41 -26%
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$125 6 -37 -86%
LTFS
53
Ladenburg Thalmann Financial Services
Florida
– – -15,350 Closed
Goldman Sachs
54
Goldman Sachs
New York
– – -12,110 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– – -1,427 Closed
CMBA
56
C.M. Bidwell & Associates
Hawaii
– – -234 Closed
1 2
3